LCN2 and early-onset autosomal dominant Alzheimer disease: Lipocalin-2 (LCN2), which is secreted by various cell types, is associated with several metabolic diseases and brain injuries such as ischemic brain disease, diabetic encephalopathy, and Alzheimer’s disease (AD) [1,2,3,4].